Waldencast (NASDAQ:WALD – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at DA Davidson in a ...

Telsey Advisory Group reiterated their outperform rating on shares of Waldencast (NASDAQ:WALD – Free Report) in a research note published on Wednesday morning,Benzinga reports. Telsey Advisory Group ...

Thank you. Allison, you may now begin. Thank you, and welcome to the Waldencast PLC fourth quarter and fiscal year 2024 earnings call. Here with me today are Michel Brousset, Founder and Chief ...

Michel Brousset, Waldencast Founder and CEO, said: “We closed a transformative year for the Group, achieving outstanding growth, expanding our brands' communities, and making significant ...

CEO Michel Brousset highlighted that 2024 was a transformative year for Waldencast, driven by strong performance from its two flagship brands: Milk Makeup and Obagi Medical. He emphasized their ...

Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023FY 2024 Net ...

Waldencast Acquisition Corp (WALD) reported its fourth-quarter 2024 earnings, revealing an earnings per share (EPS) of -$0.06, slightly missing analysts’ expectations of -$0.0524. The company ...

Waldencast Acquisition Corp (WALD) reported its fourth-quarter 2024 earnings, revealing an earnings per share (EPS) of -$0.06, slightly missing analysts’ expectations of -$0.0524. The company’s ...

Waldencast reports Q4 2024 net revenue of $72.1 million, 29.4% growth, and $11.2 million adjusted EBITDA, doubling year-over-year. Net Loss decreased only slightly from $32.7 million in Q4 2023 to ...

TD Cowen lowered the firm’s price target on Waldencast (WALD) to $3.40 from $4.30 and keeps a Hold rating on the shares. The firm updated its model following Q4 results which saw weaker than ...